Your browser doesn't support javascript.
loading
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells.
Kumar, Harish; Chattopadhyay, Sourav; Das, Nabanita; Shree, Sonal; Patel, Dinesh; Mohapatra, Jogeswar; Gurjar, Anagha; Kushwaha, Sapana; Singh, Abhishek Kumar; Dubey, Shikha; Lata, Kiran; Kushwaha, Rajesh; Mohammed, Riyazuddin; Dastidar, Krishnarup Ghosh; Yadav, Namrata; Vishwakarma, Achchhe Lal; Gayen, Jiaur Rahaman; Bandyopadhyay, Sanghamitra; Chatterjee, Abhijit; Jain, Mukul Rameshchandra; Tripathi, Anil Kumar; Trivedi, Arun Kumar; Chattopadhyay, Naibedya; Ramachandran, Ravishankar; Sanyal, Sabyasachi.
Afiliación
  • Kumar H; Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow.
  • Chattopadhyay S; Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow.
  • Das N; AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow.
  • Shree S; Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow.
  • Patel D; Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow.
  • Mohapatra J; Zydus Research Center, Moraiya, Ahmedabad, Gujarat.
  • Gurjar A; Zydus Research Center, Moraiya, Ahmedabad, Gujarat.
  • Kushwaha S; Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow.
  • Singh AK; AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow.
  • Dubey S; Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow.
  • Lata K; Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow.
  • Kushwaha R; Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow.
  • Mohammed R; Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow.
  • Dastidar KG; Developmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow.
  • Yadav N; Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute, Lucknow.
  • Vishwakarma AL; Zydus Research Center, Moraiya, Ahmedabad, Gujarat.
  • Gayen JR; Zydus Research Center, Moraiya, Ahmedabad, Gujarat.
  • Bandyopadhyay S; Sophisticated Analytical Instrument Facility, CSIR-Central Drug Research Institute, Lucknow.
  • Chatterjee A; Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute, Lucknow.
  • Jain MR; AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow.
  • Tripathi AK; Developmental Toxicology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow.
  • Trivedi AK; Zydus Research Center, Moraiya, Ahmedabad, Gujarat.
  • Chattopadhyay N; Zydus Research Center, Moraiya, Ahmedabad, Gujarat.
  • Ramachandran R; Department of Clinical Hematology and Medical Oncology, King George's Medical University, Lucknow, Uttar Pradesh.
  • Sanyal S; Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow.
Haematologica ; 105(4): 971-986, 2020 04.
Article en En | MEDLINE | ID: mdl-31371410
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Leucemia Mielógena Crónica BCR-ABL Positiva / Lepra Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Leucemia Mielógena Crónica BCR-ABL Positiva / Lepra Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article Pais de publicación: Italia